skip to Main Content

INVESTOR INFORMATION

CAPITALIZATION TABLE

CAPITALIZED FOR GROWTH

Canntab Pie chart Capitalized for Growth

OVERVIEW

• We have a clear vision to become a leader in oral dosage cannabis, with unique products that offer advantages to the medical community, patients, adult use consumers and governments.

• Clear and sustainable competitive advantage through robust intellectual property with 13 patents pending in the United States and Canada.

• Well financed, publicly traded on the CSE:PILL | OTC:CTABF | FSE:TBF1

• We’ve created valuable licensing and joint venture deals in Canada and international markets, such as Australia and Mexico.

• With Recent Sales License Approval for our partner FSD Pharma from Health Canada, this opens the door for our Canadian and International Sales and White Labeling.

• Robust new product development, including the development of 420 Therapeutics, with the goal to be a leader in the wellness category.

• Established Leadership with a Track Record of Driving Value.

CONTACT US

Interested in what we do? Want to learn more about the opportunities we offer? Get in touch, enter your information and ask any questions you may have. We'll be sure to respond as soon as possible.

You can also reach us at Info@Canntab.ca

CONTACT US

Interested in what we do? Want to learn more about the opportunities we offer? Get in touch, enter your information and ask any questions you may have. We'll be sure to respond as soon as possible.

Sign up for our monthly newsletter and keep up to date as we move toward product sales in 2019!

Back To Top